Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 287-296

Adis International

Access to resources Recommend Favorite

An Analysis of the Need for an Additional Uncertainty Factor for Infants and Children

By Renwick A.G.   Dorne J.L.   Walton K.  

Regulatory Toxicology and Pharmacology, Vol. 31, Iss. 3, 2000-06 ,pp. : 286-296

Academic Press

Access to resources Recommend Favorite

Uncertainty Analysis of Relative Biological Effectiveness of Alpha-Radiation for Human Lung Exposure

By Yarmoshenko Ilia   Kirdin Ivan   Zhukovsky Michael  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 7-8, 2006-05 ,pp. : 665-679

Taylor & Francis Ltd

Access to resources Recommend Favorite

Human Variability and Noncancer Risk Assessment- An Analysis of the Default Uncertainty Factor

By Renwick A.G.   Lazarus N.R.  

Regulatory Toxicology and Pharmacology, Vol. 27, Iss. 1, 1998-02 ,pp. : 3-20

Academic Press

Access to resources Recommend Favorite